HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Platelet Factor 3 (PF 3)

A phospholipid from the platelet membrane that contributes to the blood clotting cascade by forming a phospholipid-protein complex (THROMBOPLASTIN) which serves as a cofactor with FACTOR VIIA to activate FACTOR X in the extrinsic pathway of BLOOD COAGULATION.
Also Known As:
PF 3; Factor 3, Platelet; Blood platelet factor 3
Networked: 79 relevant articles (3 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hofman, Zandrie: 1 article (07/2021)
2. Kaul, Sundeep: 1 article (07/2021)
3. Klebach, Marianne: 1 article (07/2021)
4. Tsompanaki, Eleni: 1 article (07/2021)
5. de Brito-Ashurst, Ione: 1 article (07/2021)
6. van Horssen, Peter: 1 article (07/2021)
7. Angebault, Cécile: 1 article (04/2021)
8. Aït-Ammar, Nawel: 1 article (04/2021)
9. Botterel, Françoise: 1 article (04/2021)
10. Flateau, Clara: 1 article (04/2021)

Related Diseases

1. Hemorrhage
2. Pain (Aches)
01/01/1977 - "2. Platelet factor 3 (PF3) availability was found to be increased in patients with the loin pain and haematuria syndrome during normal menstrual cycles. "
01/01/1977 - "The effect of oestrogen-containing compounds on platelet factor 3, platelet life span, renal platelet localization and the fibrinolytic activity of forearm venous blood has been studied in eleven women with the renal vascular abnormalities of the loin pain and haematuria syndrome. "
01/01/2020 - "The objectives of this study were (1) to investigate the passive stiffness of the medial gastrocnemius (MG) and lateral gastrocnemius (LG) in patients with and without plantar fasciitis (PF), (2) to explore the correlation between gastrocnemius stiffness and plantar fascia thickness (PFT) as well as the intensity of pain in patients with PF, (3) to detect optimal cut-off points for stiffness of the MG and LG for identifying patients with PF. "
01/01/2019 - "Complete the self-assessment activity and evaluation online at http://www.physiatry.org/JournalCME CME OBJECTIVES: Upon completion of this article, the reader should be able to: (1) Compare the efficacy of whole blood (WB), platelet-rich plasma (PRP), and corticosteroid (CS) in short-term pain reduction in patients with plantar fasciopathy (PF); (2) Compare the efficacy of WB, PRP, and CS in long-term pain reduction in patients with PF; (3) Identify the potential complication of corticosteroid injection for plantar fasciopathy; and (4) Identify the components of whole blood that might influence the growth factors in healing process. "
3. Thrombocytopenia (Thrombopenia)
4. Blastomycosis
5. Stroke (Strokes)

Related Drugs and Biologics

1. Antinuclear Antibodies
2. Intercellular Signaling Peptides and Proteins (Growth Factors)
3. Agar
4. Adrenal Cortex Hormones (Corticosteroids)
5. Phosphatidylethanolamines (Cephalins)
6. Kaolin
7. Factor V (Coagulation Factor V)
8. Adenosine Diphosphate (ADP)
9. Epinephrine (Adrenaline)
10. Phospholipids (Phosphatides)

Related Therapies and Procedures

1. Blood Vessel Prosthesis